Browsing by Author UCSF Helen Diller Family Comprehensive Cancer Center

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 3 to 4 of 4 < previous 
Issue DateTitleAuthor(s)
20-Jan-2018Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinomaMilind Javle; Maeve Lowery; Rachna T. Shroff; Karl Heinz Weiss; Christoph Springfeld; Mitesh J. Borad; Ramesh K. Ramanathan; Lipika Goyal; Saeed Sadeghi; Teresa Macarulla; Anthony El-Khoueiry; Robin Kate Kelley; Ivan Borbath; Su Pin Choo; Do Youn Oh; Philip A. Philip; Li Tzong Chen; Thanyanan Reungwetwattana; Eric Van Cutsem; Kun Huei Yeh; Kristen Ciombor; Richard S. Finn; Anuradha Patel; Suman Sen; Dale Porter; Randi Isaacs; Andrew X. Zhu; Ghassan K. Abou-Alfa; Tanios Bekaii-Saab; National Cheng Kung University Hospital; Barbara Ann Karmanos Cancer Institute; National Cancer Centre, Singapore; KU Leuven– University Hospital Leuven; UCSF Helen Diller Family Comprehensive Cancer Center; Mayo Clinic Scottsdale-Phoenix, Arizona; National Taiwan University College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Keck School of Medicine of USC; University of Texas MD Anderson Cancer Center; Seoul National University; Cliniques Universitaires Saint-Luc, Brussels; Hospital Universitari Vall d'Hebron; Memorial Sloan-Kettering Cancer Center; David Geffen School of Medicine at UCLA; Ohio State University; Universitätsklinikum Heidelberg; Massachusetts General Hospital Cancer Center; Novartis Pharmaceuticals Corporation
1-Jan-2013Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2Kathleen I. Pritchard; Howard A. Burris; Yoshinori Ito; Hope S. Rugo; Shaker Dakhil; Gabriel N. Hortobagyi; Mario Campone; Tibor Csöszi; José Baselga; Puttisak Puttawibul; Martine Piccart; Daniel Heng; Shinzaburo Noguchi; Vichien Srimuninnimit; Hugues Bourgeois; Antonio Gonzalez Martin; Karen Osborne; Ashok Panneerselvam; Tetiana Taran; Tarek Sahmoud; Michael Gnant; University of Toronto; Sarah Cannon Research Institute; Cancer Institute Hospital of Japan Foundation for Cancer Research; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Center of Kansas; University of Texas MD Anderson Cancer Center; Centre de Recherche en Cancérologie; Hetenyi Geza County Hospital; Memorial Sloan-Kettering Cancer Center; Prince of Songkla University; Institut Jules Bordet; University of Calgary; Osaka University; Mahidol University; Centre Jean Bernard; MD Anderson Cancer Center, Madrid; Novartis International AG; Novartis Pharmaceuticals Corporation; Medizinische Universitat Wien